Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 12  •  04:00PM ET
16.97
Dollar change
-0.40
Percentage change
-2.30
%
Index- P/E87.93 EPS (ttm)0.19 Insider Own22.47% Shs Outstand284.09M Perf Week-2.47%
Market Cap4.82B Forward P/E18.09 EPS next Y0.94 Insider Trans-62.59% Shs Float220.26M Perf Month-10.59%
Enterprise Value6.80B PEG1.28 EPS next Q0.24 Inst Own60.83% Short Float3.03% Perf Quarter5.21%
Income55.42M P/S4.19 EPS this Y19.83% Inst Trans5.65% Short Ratio3.16 Perf Half Y7.95%
Sales1.15B P/B8.76 EPS next Y11.84% ROA1.75% Short Interest6.67M Perf YTD-3.80%
Book/sh1.94 P/C16.02 EPS next 5Y14.13% ROE10.86% 52W High19.85 -14.51% Perf Year26.74%
Cash/sh1.06 P/FCF42.01 EPS past 3/5Y-27.77% - ROIC1.98% 52W Low9.53 78.07% Perf 3Y1.31%
Dividend Est.- EV/EBITDA12.38 Sales past 3/5Y5.71% 7.17% Gross Margin52.23% Volatility3.00% 2.88% Perf 5Y-39.00%
Dividend TTM- EV/Sales5.91 EPS Y/Y TTM-21.96% Oper. Margin35.09% ATR (14)0.53 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.16 Sales Y/Y TTM2.67% Profit Margin4.82% RSI (14)33.12 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio2.38 EPS Q/Q183.70% SMA20-6.77% Beta1.83 Target Price20.44
Payout0.00% Debt/Eq4.14 Sales Q/Q9.05% SMA50-4.83% Rel Volume0.84 Prev Close17.37
Employees3000 LT Debt/Eq4.10 EarningsNov 04 BMO SMA20012.68% Avg Volume2.11M Price16.97
IPONov 20, 2020 Option/ShortYes / Yes EPS/Sales Surpr.19.16% 2.52% Trades Volume1,778,842 Change-2.30%
Date Action Analyst Rating Change Price Target Change
Jan-09-26Upgrade Piper Sandler Neutral → Overweight $24
Jan-09-26Resumed RBC Capital Mkts Outperform $24
Dec-18-25Initiated William Blair Outperform
Nov-13-25Initiated BMO Capital Markets Outperform $19
May-05-25Upgrade Goldman Neutral → Buy $17
Dec-06-24Initiated Goldman Neutral $14
May-21-24Initiated Piper Sandler Neutral $13
Apr-03-24Upgrade Citigroup Neutral → Buy $18 → $16
Mar-25-24Upgrade Jefferies Hold → Buy $15 → $15.50
Feb-06-24Resumed KeyBanc Capital Markets Sector Weight
Feb-05-26 07:30AM
Jan-18-26 11:04PM
Jan-14-26 11:34PM
Jan-12-26 07:00AM
Jan-07-26 07:30AM
03:11PM Loading…
Dec-30-25 03:11PM
Dec-23-25 10:36PM
Dec-22-25 11:32PM
Nov-25-25 09:15AM
Nov-06-25 04:37PM
Nov-04-25 04:12PM
09:30AM
08:45AM
07:20AM
07:00AM
07:25AM Loading…
Nov-03-25 07:25AM
Nov-02-25 10:02PM
Oct-30-25 12:31AM
Oct-21-25 05:13PM
Oct-17-25 12:48AM
Sep-11-25 12:01AM
Sep-08-25 12:37AM
Sep-04-25 12:16PM
Sep-03-25 04:57PM
Aug-27-25 09:55AM
Aug-20-25 11:35PM
Aug-15-25 01:31AM
Aug-14-25 12:44AM
Aug-13-25 05:51PM
Aug-11-25 09:47AM
03:08AM Loading…
Aug-09-25 03:08AM
Aug-08-25 01:00PM
12:21PM
07:35AM
07:30AM
Aug-07-25 09:15AM
09:15AM
Aug-06-25 11:01PM
Aug-05-25 06:05PM
12:37AM
Jul-28-25 07:38AM
Jul-22-25 12:33AM
Jul-21-25 01:16PM
07:06AM
Jul-04-25 12:33AM
Jun-26-25 03:57AM
Jun-20-25 12:01AM
Jun-18-25 07:39AM
Jun-04-25 07:55AM
May-15-25 03:41PM
May-02-25 02:37PM
03:10AM
May-01-25 09:30AM
08:55AM
07:38AM
Apr-30-25 05:50PM
Apr-17-25 05:16PM
Apr-14-25 10:08AM
05:12AM
Apr-08-25 12:34PM
Mar-25-25 07:50AM
Mar-12-25 05:03AM
Mar-04-25 07:00AM
Feb-28-25 04:30AM
02:22AM
Feb-27-25 03:45PM
09:30AM
08:40AM
07:15AM
07:00AM
Feb-26-25 08:13AM
07:19AM
Feb-24-25 09:16AM
Feb-18-25 04:30PM
Feb-17-25 08:44AM
Jan-14-25 07:30AM
Jan-12-25 09:25AM
Jan-07-25 04:30PM
Jan-06-25 04:30PM
Dec-18-24 07:00AM
Nov-20-24 09:00AM
Nov-06-24 02:16AM
01:44AM
Nov-05-24 01:00PM
10:00AM
08:25AM
07:00AM
Nov-04-24 07:04AM
Oct-29-24 10:01AM
Oct-22-24 04:30PM
Oct-08-24 11:23AM
Sep-14-24 01:53AM
Sep-10-24 03:16PM
Sep-04-24 04:41PM
Aug-05-24 11:10PM
04:00PM
09:30AM
08:15AM
07:28AM
07:00AM
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petras Michael B. Jr.Chairman & CEODec 08 '25Sale16.45434,1047,141,0110Dec 10 04:43 PM
Petras Michael B. Jr.Chairman & CEODec 08 '25Sale16.45315,8965,196,489552,790Dec 10 04:43 PM
Michael B. Petras, Jr.Chairman, CEODec 08 '25Proposed Sale16.75750,00012,562,500Dec 08 05:11 PM
WARBURG PINCUS & CO.DirectorDec 03 '25Sale16.339,720,000158,727,60034,102,952Dec 05 08:47 PM
WARBURG PINCUS & CO.DirectorDec 03 '25Sale16.339,720,000158,727,60034,102,952Dec 05 08:43 PM
GTCR INVESTMENT XI LLCDirectorDec 03 '25Sale16.336,480,000105,818,40022,735,301Dec 05 08:10 PM
GTCR FUND XI/C LP OwnerDec 03 '25Proposed Sale16.331,295,74721,159,549Dec 04 06:01 AM
GTCR CO-INVEST XI LP OwnerDec 03 '25Proposed Sale16.3341,219673,106Dec 03 09:59 PM
GTCR FUND XI/A LP OwnerDec 03 '25Proposed Sale16.335,143,03383,985,729Dec 03 09:59 PM
WARBURG PINCUS LLCAffiliateDec 03 '25Proposed Sale16.849,720,000163,684,800Dec 03 08:53 PM
GTCR INVESTMENT XI LLCDirectorNov 10 '25Sale15.6512,000,000187,812,00029,215,301Nov 12 05:06 PM
WARBURG PINCUS & CO.DirectorNov 10 '25Sale15.6518,000,000281,718,00043,822,952Nov 12 04:18 PM
WARBURG PINCUS & CO.DirectorNov 10 '25Sale15.6518,000,000281,718,00043,822,952Nov 12 04:11 PM
WARBURG PINCUS & CO.DirectorSep 05 '25Sale15.1112,000,000181,332,00061,822,952Sep 09 09:41 PM
WARBURG PINCUS & CO.DirectorSep 05 '25Sale15.1112,000,000181,332,00061,822,952Sep 09 09:37 PM
GTCR INVESTMENT XI LLCDirectorSep 05 '25Sale15.118,000,000120,888,00041,215,301Sep 09 08:41 PM
Rutz Michael PPresident of SterigenicsAug 22 '25Sale16.38126,6112,074,306450,204Aug 26 06:08 PM
Rutz Michael POfficerAug 22 '25Proposed Sale16.12126,6112,040,969Aug 22 10:46 AM
Last Close
Feb 12  •  04:00PM ET
3.02
Dollar change
-0.10
Percentage change
-3.21
%
MRVI Maravai LifeSciences Holdings Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.84 Insider Own27.07% Shs Outstand144.72M Perf Week-2.27%
Market Cap772.24M Forward P/E- EPS next Y-0.20 Insider Trans0.83% Shs Float105.76M Perf Month-24.88%
Enterprise Value1.08B PEG- EPS next Q-0.07 Inst Own77.34% Short Float10.67% Perf Quarter-7.08%
Income-121.24M P/S4.02 EPS this Y-212.44% Inst Trans2.65% Short Ratio9.07 Perf Half Y9.82%
Sales192.28M P/B1.78 EPS next Y34.96% ROA-11.40% Short Interest11.29M Perf YTD-7.08%
Book/sh1.70 P/C3.17 EPS next 5Y-19.12% ROE-41.06% 52W High4.40 -31.36% Perf Year-29.11%
Cash/sh0.95 P/FCF- EPS past 3/5Y- -64.27% ROIC-20.24% 52W Low1.66 81.38% Perf 3Y-78.37%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-31.30% 12.61% Gross Margin19.61% Volatility4.48% 5.43% Perf 5Y-91.25%
Dividend TTM- EV/Sales5.63 EPS Y/Y TTM48.79% Oper. Margin-50.79% ATR (14)0.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.56 Sales Y/Y TTM-30.56% Profit Margin-63.05% RSI (14)31.89 Recom2.09
Dividend Gr. 3/5Y- - Current Ratio5.29 EPS Q/Q74.76% SMA20-12.39% Beta0.40 Target Price3.93
Payout- Debt/Eq1.50 Sales Q/Q-36.15% SMA50-14.75% Rel Volume0.85 Prev Close3.12
Employees570 LT Debt/Eq1.44 EarningsFeb 25 AMC SMA2004.87% Avg Volume1.24M Price3.02
IPONov 20, 2020 Option/ShortYes / Yes EPS/Sales Surpr.2.56% -15.08% Trades Volume1,052,087 Change-3.21%
Date Action Analyst Rating Change Price Target Change
Feb-26-25Downgrade Robert W. Baird Outperform → Neutral $9 → $3
Dec-19-24Initiated Guggenheim Neutral
Dec-05-24Downgrade Goldman Neutral → Sell $4.25
Nov-14-24Initiated Wolfe Research Peer Perform
Nov-08-24Downgrade William Blair Outperform → Mkt Perform
Aug-28-24Initiated Wells Fargo Overweight $10
Aug-13-24Downgrade Morgan Stanley Overweight → Equal-Weight $11 → $10
Apr-10-24Initiated Craig Hallum Buy $15
Dec-12-23Upgrade BofA Securities Neutral → Buy $10 → $8
Aug-08-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-09-26 05:05PM
Nov-10-25 08:00AM
Nov-07-25 12:12AM
Nov-06-25 06:15PM
04:01PM
09:05AM Loading…
Nov-04-25 09:05AM
Oct-22-25 04:01PM
Aug-12-25 03:07AM
Aug-11-25 07:00PM
04:05PM
Jul-28-25 05:08PM
Jun-25-25 04:01PM
Jun-09-25 08:30AM
Jun-03-25 10:00AM
May-21-25 04:22PM
04:05PM Loading…
04:05PM
May-20-25 08:00AM
May-14-25 04:00PM
May-13-25 09:30AM
03:11AM
May-12-25 05:20PM
04:06PM
May-08-25 05:10PM
May-07-25 07:10PM
May-05-25 05:47AM
May-01-25 05:20PM
07:30AM
Apr-24-25 12:27PM
Apr-22-25 05:45AM
Apr-16-25 06:10PM
09:35AM Loading…
Apr-15-25 09:35AM
Apr-14-25 01:13PM
Apr-11-25 01:31PM
Apr-10-25 11:34AM
04:37AM
Apr-04-25 02:34PM
Apr-03-25 06:21PM
Apr-01-25 01:23PM
Mar-26-25 11:10AM
Mar-25-25 12:49PM
Mar-24-25 02:33PM
Mar-22-25 10:30AM
Mar-21-25 08:00PM
01:43PM
Mar-20-25 09:00PM
Mar-18-25 04:05PM
05:45AM
Mar-17-25 02:22AM
Mar-16-25 09:32AM
Mar-08-25 10:15AM
Feb-28-25 09:31AM
Feb-27-25 06:37PM
Feb-25-25 06:00AM
Feb-24-25 08:00AM
Feb-04-25 04:01PM
Feb-03-25 06:00AM
Jan-28-25 04:01PM
Jan-20-25 11:02PM
Jan-08-25 04:10PM
Dec-20-24 07:15AM
Dec-05-24 04:05PM
Nov-12-24 08:05AM
Nov-09-24 06:51AM
Nov-08-24 02:20PM
03:15AM
02:34AM
Nov-07-24 04:01PM
04:01PM
Oct-15-24 04:05PM
Oct-09-24 08:03AM
Sep-24-24 08:12AM
Aug-28-24 07:49AM
Aug-12-24 08:05AM
Aug-08-24 12:45AM
Aug-07-24 04:05PM
Jul-29-24 04:05PM
Jul-10-24 08:00AM
Jul-02-24 04:00PM
Jun-20-24 09:15AM
Jun-17-24 09:54AM
Jun-12-24 02:38AM
May-17-24 11:52AM
May-13-24 08:00AM
May-09-24 04:18PM
04:05PM
10:53AM
10:11AM
04:02AM
03:15AM
May-08-24 08:57PM
04:05PM
Apr-30-24 07:31AM
Apr-18-24 07:36AM
Apr-10-24 04:05PM
Mar-28-24 04:00PM
Mar-19-24 07:48AM
Mar-12-24 04:15PM
Feb-23-24 12:15PM
10:10AM
Feb-22-24 08:30PM
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRAHALAD MURALIFormer DirectorDec 23 '25Proposed Sale3.333,95113,138Dec 23 03:00 PM
Hopfield JessicaFormer DirectorDec 19 '25Proposed Sale3.4853,951187,526Dec 19 04:38 PM
LUCIER GREGORY TDirectorDec 05 '25Buy3.7051,472190,446106,595Dec 09 04:36 PM
LUCIER GREGORY TDirectorDec 08 '25Buy3.6748,528178,098155,123Dec 09 04:36 PM
Brust BerndChief Executive OfficerNov 13 '25Buy3.25216,212702,689466,771Nov 17 04:48 PM
Brust BerndChief Executive OfficerNov 11 '25Buy3.24157,201509,331157,201Nov 13 05:27 PM
Brust BerndChief Executive OfficerNov 12 '25Buy3.2193,358299,679250,559Nov 13 05:27 PM